18
Participants
Start Date
November 30, 2006
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
Zoledronic acid
Hillman Cancer Center, Pittsburgh
Virginia Cancer Institute Virginia Cancer Center, Richmond
Oncotherapeutics, West Hollywood
Rocky Mountain Cancer Centers RMCC, Greenwood Village
Norwalk Hospital, Norwalk
Huntsman Cancer Institute Univ. of Utah, Salt Lake City
University of Vermont Fletcher Allen Health Care, Burlington
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY